ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 753769 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 753769; 2) Community: the network communities that were significantly associated with the response to NSC 753769; 3) Molecule: the relationships between components within communities and NSC 753769; 4) MDR: the compounds that were significantly associated with the NSC 753769.

NSC Compound Enrichment Correlation
NSC 85701 Quinolinium, 6-ethoxy-2-[2-(8-hydroxy-5-quinolyl)vinyl]-1-methyl- iodide 0.0342636096654271 0.24284227
NSC 755426 Null 0.0342636096654276 0.14736131
NSC 763621 (Z)-3-((2-(4-(trifluoromethyl)phenyl)-3H-benzo[d]imidazol-5-yl)methylene)indolin-2-one 0.0342636096654276 0.0056506445
NSC 762557 Null 0.0385613993886 0.49273473
NSC 113497 16,17-Seco-24-nor-5.alpha.,13.alpha.,14.beta.,17.alpha.-chola-1,20,22-trien-16-oic acid, 14,15.beta.:21,23-diepoxy-7.alpha.,17-dihydroxy-4,4,8-trimethyl-3-oxo-, 16,17-lactone, acetate (8CI) 0.0385613993886001 -0.23117034
NSC 119915 3-(4,5,6-trihydroxy-3-oxo-3H-xanthen-9-yl)propanoic acid 0.0385613993886001 0.019356909
NSC 129790 Null 0.0385613993886001 -0.17920104
NSC 135037 Jatrophone 0.0385613993886001 -0.13732437
NSC 18805 .gamma.-Thujaplicine 0.0385613993886001 -0.015675591
NSC 23925 Null 0.0385613993886001 -0.31662887
Total:59  Current:37    [First] [Prev] [Next] [Last]